233 related articles for article (PubMed ID: 21789170)
1. Metabolomic profiling reveals a role for androgen in activating amino acid metabolism and methylation in prostate cancer cells.
Putluri N; Shojaie A; Vasu VT; Nalluri S; Vareed SK; Putluri V; Vivekanandan-Giri A; Byun J; Pennathur S; Sana TR; Fischer SM; Palapattu GS; Creighton CJ; Michailidis G; Sreekumar A
PLoS One; 2011; 6(7):e21417. PubMed ID: 21789170
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer.
Lucarelli G; Rutigliano M; Galleggiante V; Giglio A; Palazzo S; Ferro M; Simone C; Bettocchi C; Battaglia M; Ditonno P
Expert Rev Mol Diagn; 2015; 15(9):1211-24. PubMed ID: 26174441
[TBL] [Abstract][Full Text] [Related]
3. TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancer.
Takayama K; Horie-Inoue K; Suzuki T; Urano T; Ikeda K; Fujimura T; Takahashi S; Homma Y; Ouchi Y; Inoue S
Mol Endocrinol; 2012 May; 26(5):748-61. PubMed ID: 22456197
[TBL] [Abstract][Full Text] [Related]
4. Androgen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile.
Vaz CV; Alves MG; Marques R; Moreira PI; Oliveira PF; Maia CJ; Socorro S
Int J Biochem Cell Biol; 2012 Nov; 44(11):2077-84. PubMed ID: 22964025
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.
Sreekumar A; Poisson LM; Rajendiran TM; Khan AP; Cao Q; Yu J; Laxman B; Mehra R; Lonigro RJ; Li Y; Nyati MK; Ahsan A; Kalyana-Sundaram S; Han B; Cao X; Byun J; Omenn GS; Ghosh D; Pennathur S; Alexander DC; Berger A; Shuster JR; Wei JT; Varambally S; Beecher C; Chinnaiyan AM
Nature; 2009 Feb; 457(7231):910-4. PubMed ID: 19212411
[TBL] [Abstract][Full Text] [Related]
6. Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancer.
Saraon P; Musrap N; Cretu D; Karagiannis GS; Batruch I; Smith C; Drabovich AP; Trudel D; van der Kwast T; Morrissey C; Jarvi KA; Diamandis EP
J Biol Chem; 2012 Oct; 287(41):34019-31. PubMed ID: 22908226
[TBL] [Abstract][Full Text] [Related]
7. Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation.
Cardoso HJ; Figueira MI; Vaz CV; Carvalho TMA; Brás LA; Madureira PA; Oliveira PJ; Sardão VA; Socorro S
Cell Oncol (Dordr); 2021 Apr; 44(2):385-403. PubMed ID: 33464483
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic effects of androgen deprivation therapy treatment for prostate cancer.
Chi JT; Lin PH; Tolstikov V; Oyekunle T; Chen EY; Bussberg V; Greenwood B; Sarangarajan R; Narain NR; Kiebish MA; Freedland SJ
Cancer Med; 2020 Jun; 9(11):3691-3702. PubMed ID: 32232974
[TBL] [Abstract][Full Text] [Related]
9. GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling.
White MA; Tsouko E; Lin C; Rajapakshe K; Spencer JM; Wilkenfeld SR; Vakili SS; Pulliam TL; Awad D; Nikolos F; Katreddy RR; Kaipparettu BA; Sreekumar A; Zhang X; Cheung E; Coarfa C; Frigo DE
Endocr Relat Cancer; 2018 Apr; 25(4):453-469. PubMed ID: 29431615
[TBL] [Abstract][Full Text] [Related]
10. "Topological significance" analysis of gene expression and proteomic profiles from prostate cancer cells reveals key mechanisms of androgen response.
Vellaichamy A; Dezso Z; JeBailey L; Chinnaiyan AM; Sreekumar A; Nesvizhskii AI; Omenn GS; Bugrim A
PLoS One; 2010 Jun; 5(6):e10936. PubMed ID: 20532174
[TBL] [Abstract][Full Text] [Related]
11. Melatonin Decreases Glucose Metabolism in Prostate Cancer Cells: A
Hevia D; Gonzalez-Menendez P; Fernandez-Fernandez M; Cueto S; Rodriguez-Gonzalez P; Garcia-Alonso JI; Mayo JC; Sainz RM
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28933733
[TBL] [Abstract][Full Text] [Related]
12. Induction of FLIP expression by androgens protects prostate cancer cells from TRAIL-mediated apoptosis.
Raclaw KA; Heemers HV; Kidd EM; Dehm SM; Tindall DJ
Prostate; 2008 Nov; 68(15):1696-706. PubMed ID: 18726983
[TBL] [Abstract][Full Text] [Related]
13. RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.
Schmidt LJ; Duncan K; Yadav N; Regan KM; Verone AR; Lohse CM; Pop EA; Attwood K; Wilding G; Mohler JL; Sebo TJ; Tindall DJ; Heemers HV
Mol Endocrinol; 2012 May; 26(5):716-35. PubMed ID: 22456196
[TBL] [Abstract][Full Text] [Related]
14. Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.
Montgomery RB; Mostaghel EA; Vessella R; Hess DL; Kalhorn TF; Higano CS; True LD; Nelson PS
Cancer Res; 2008 Jun; 68(11):4447-54. PubMed ID: 18519708
[TBL] [Abstract][Full Text] [Related]
15. A Signaling Network Controlling Androgenic Repression of c-Fos Protein in Prostate Adenocarcinoma Cells.
Shankar E; Song K; Corum SL; Bane KL; Wang H; Kao HY; Danielpour D
J Biol Chem; 2016 Mar; 291(11):5512-5526. PubMed ID: 26786102
[TBL] [Abstract][Full Text] [Related]
16. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
[TBL] [Abstract][Full Text] [Related]
17. Metabolomic profiling identifies biochemical pathways associated with castration-resistant prostate cancer.
Kaushik AK; Vareed SK; Basu S; Putluri V; Putluri N; Panzitt K; Brennan CA; Chinnaiyan AM; Vergara IA; Erho N; Weigel NL; Mitsiades N; Shojaie A; Palapattu G; Michailidis G; Sreekumar A
J Proteome Res; 2014 Feb; 13(2):1088-100. PubMed ID: 24359151
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor involvement in the progression of prostate cancer.
Suzuki H; Ueda T; Ichikawa T; Ito H
Endocr Relat Cancer; 2003 Jun; 10(2):209-16. PubMed ID: 12790784
[TBL] [Abstract][Full Text] [Related]
19. Proteomics analyses of prostate cancer cells reveal cellular pathways associated with androgen resistance.
Höti N; Shah P; Hu Y; Yang S; Zhang H
Proteomics; 2017 Mar; 17(6):. PubMed ID: 28116790
[TBL] [Abstract][Full Text] [Related]
20. The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer.
Chatterjee B
Mol Cell Biochem; 2003 Nov; 253(1-2):89-101. PubMed ID: 14619959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
